Skip to main content

Life Sciences Float Raises £4.5 million

Life Sciences Float Raises £4.5 million

Life sciences company SkinBioTherapeutics’ placing has raised gross proceeds of £4.5m including a cornerstone investment from equity investor Seneca Partners.

Dr Catherine O’Neill, chief executive of SkinBioTherapeutics, said: “Joining AIM is a significant milestone for SkinBioTherapeutics and will give us the visibility we need amongst the established global players we look to partner with. The funds raised will enable us to progress the SkinBiotix technology platform and to accelerate the clinical development of our main therapeutic candidates. This is an exciting time to be in the microbiome space, especially with regards to skin health. We have an experienced team and board, plus the financial and shareholder support to maximise this opportunity.”

See the article in full at

Contact Us

Online form

If you would like to speak to us about an investment opportunity or would like some information on how to invest with Seneca, please contact us and a member of the team will be pleased to help you.
  • Would you like to receive Seneca Partners Newsletter updates?

  • Would you like to receive Seneca Partners Onside Magazine?

  • Would you like to receive Seneca Partners Event Updates?

  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.
Visit Seneca Partners Website